Difass obtains a new patent

On 29 of February 2024 Difass International has obtained with great pleasure and satisfaction a patent that protects the entire Dibuzin® formulation complex.

Patent’s title is: “COMPOSITIONS FOR THE TREATMENT OF DISEASES AND SYNDROMES RELATED TO INTESTINAL BARRIER DYSFUNCTION AND DYSBIOSIS’”

The patent with number 102022000003929 will last for 20 years from the filing date (02/03/2022 - 02/03/2042).

Obtaining this patent represents an added value in terms of the uniqueness of Dibuzin® product, confirming the company's strong orientation towards specialization and continuous innovation.